Smart Healthcare Products Market Size and Share

Smart Healthcare Products Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Smart Healthcare Products Market Analysis by Mordor Intelligence

The smart healthcare products market size is valued at USD 223.98 billion in 2025 and is forecast to reach USD 386.00 billion by 2030, expanding at an 11.5% CAGR through the period. Rising deployment of IoT-enabled devices, the convergence of artificial intelligence with clinical workflows, and reimbursement models that now cover remote monitoring solutions are accelerating adoption. Government incentives such as Singapore’s USD 150 million GenAI programme and the European Health Data Space Regulation are standardising data exchange, reducing integration costs, and stimulating supplier investment. Strategic partnerships among device makers, cloud providers, and hospital systems are reshaping competitive strategies, while cybersecurity regulations tighten compliance requirements. Taken together, these forces propel the smart healthcare products market, even as capital-intensive infrastructure and data-privacy concerns temper the growth trajectory.

Key Report Takeaways

  • By product type, Electronic Health Records commanded 28.51% of smart healthcare products market share in 2024; Smart Wearable Devices are projected to grow at a 19.25% CAGR to 2030.
  • By application, Remote Monitoring accounted for 42.53% of the smart healthcare products market size in 2024, whereas Wellness & Preventive Care is advancing at a 17.85% CAGR through 2030.
  • By end user, Hospitals held 50.21% share of the smart healthcare products market size in 2024, while Home-Care Settings are expanding at a 19.17% CAGR.
  • By geography, North America retained the regional lead with 37.82% share in 2024; Asia-Pacific is the fastest-growing region at a 17.31% CAGR to 2030.

Segment Analysis

By Product Type: EHR Dominance Challenged by Wearable Innovation

Electronic Health Records contributed 28.51% to overall revenue in 2024, underlining their position as the data backbone of clinical workflows. National programmes such as Vietnam’s hospital-wide digitisation of 32 million patient files reaffirm government support, ensuring sustained licensing income for platform vendors. Oracle’s USD 3.5 billion budget application for the Veterans Affairs rollout further demonstrates institutional commitment to enterprise-scale implementations. Continuous user-experience upgrades and HL7 FHIR compliance solidify switching costs. The smart healthcare products market size for EHRs is projected to expand steadily, albeit at a single-digit rate, as penetration in primary care settings plateaus in developed economies.

Smart Wearable Devices, forecast to record a 19.25% CAGR, are capturing unmet needs in ambulatory monitoring. FDA-cleared innovations such as cuffless blood-pressure monitors and wrist-based pulse detection broaden clinical acceptability. Start-ups leverage cloud connectivity and AI algorithms to offer subscription-based analytics, reducing reliance on hardware margins. Device makers embed over-the-air update pipelines that keep software current, extending product life and service revenue. The smart healthcare products market size for wearables is therefore positioned for outsized expansion relative to other device classes.

Parallel segments play supporting roles. Telemedicine Platforms integrate wearables into virtual-care visits, while Smart Pills gain traction in gastrointestinal diagnostics following FDA De Novo clearance for blood detection. Smart RFID Cabinets protect high-value consumables, cutting inventory shrinkage by up to 15% and improving compliance with chain-of-custody mandates. Investments in smart hospital infrastructure, such as Siemens’ deployment of 7,000 IoT sensors at Kantonsspital Baden, illustrate growing end-to-end integration across the smart healthcare products market.

Smart Healthcare Products Market: Market Share by Product Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Application: Remote Monitoring Leads Preventive Care Revolution

Remote Monitoring held 42.53% share in 2024, underpinned by proven reductions in readmissions and payer reimbursement structures that incentivise home-based care. The United States market alone is expected to double from USD 14-15 billion in 2024 to more than USD 29 billion by 2030. Providers integrate RPM dashboards within EHRs to trigger alerts, enhancing care-team efficiency. Commercial insurers now couple premium discounts with validated device utilisation, encouraging patient engagement. Consequently, the smart healthcare products market share associated with remote monitoring retains momentum throughout the forecast window.

Wellness & Preventive Care, advancing at a 17.85% CAGR, benefits from rising consumer interest in proactive health. AI-powered full-body MRI solutions illustrate how early detection reduces downstream treatment costs. Corporate wellness programmes reimburse employees for wearables that track sleep, stress, and activity, expanding addressable demand. Diagnostics segments apply machine-learning algorithms to imaging and laboratory data, cutting false positives and expediting treatment decisions. Treatment & Drug-Delivery applications incorporate smart pills with targeted release, improving adherence. Storage & Inventory Management leverages IoT cabinets to shorten restocking cycles and lower waste, reinforcing operational efficiencies across the smart healthcare products market.

By End User: Hospitals Maintain Leadership as Home Care Accelerates

Hospitals generated 50.21% of total revenue in 2024, leveraging established infrastructure and high patient throughput. Multi-year alliances such as GE HealthCare’s seven-year agreement with Sutter Health cover 300 facilities and integrate AI-based imaging across radiology workflows. Investments in predictive maintenance for imaging scanners and smart operating theatres provide incremental efficiency gains, retaining hospital dominance within the smart healthcare products market.

Home-Care Settings are forecast to grow at a 19.17% CAGR as shifting demographics and reimbursement flexibility favour decentralised care. Medicare policy now allows audio-only telehealth for specific chronic conditions, expanding access for digitally constrained populations. FDA-cleared consumer devices, including over-the-counter glucose monitors and nasal-congestion wearables, empower self-management and reduce clinic visits. Specialty Clinics deploy disease-specific dashboards that integrate imaging AI, while Ambulatory Surgical Centers attach disposable sensors to post-operative patients, lowering complications. Long-Term Care Facilities implement fall-detection beacons and smart mattresses, trimming adverse events. These deployments collectively reinforce revenue diversification across the smart healthcare products market.

Smart Healthcare Products Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

North America retained 37.82% revenue share in 2024, buoyed by sophisticated payer systems, advanced infrastructure, and sizeable venture capital flows. Federal initiatives such as the ARPA-H Women’s Health Sprint, which committed more than USD 100 million to digital health research, strengthen the innovation pipeline. Medicare’s extension of telehealth flexibilities through 2025 further entrenches remote monitoring usage and stabilises supplier demand. Canada complements the region’s dynamism by launching the Infoway Centre for Clinical Innovation to foster standards-based interoperability. Strong cybersecurity oversight in both countries ensures continued investment despite breach headlines.

Asia-Pacific delivers the fastest CAGR at 17.31% thanks to coordinated national strategies, expanding middle-class populations, and unmet clinical demand in rural areas. Singapore’s five-year USD 150 million GenAI plan fast-tracks imaging AI and automated record transcription across public hospitals. South Korea allocates USD 830 million for AI-enabled emergency systems, setting benchmarks for real-time patient transfer management. Southeast Asia’s digital health revenue is poised to reach USD 6.1 billion in 2024, with investors attracted to high smartphone penetration and supply-demand gaps. Australia’s Health Connect platform promotes seamless data sharing, accelerating provider onboarding.

Europe benefits from the European Health Data Space Regulation, effective March 2025, setting a single market for digital health services and supporting projects such as Xt-EHR and EUVAC. Unified rules reduce vendor fragmentation and encourage cross-border telemedicine. National health systems in Germany and France have rolled out e-prescription mandates, underlining commitment to digitalisation. In the Middle East and Africa, South Africa pilots national e-health strategies, while Gulf Cooperation Council states invest in smart hospital builds. South America shows momentum, particularly in Brazil where urbanisation and private insurance uptake fuel demand, although macroeconomic volatility moderates growth. Overall, geographic diversification balances expansion risks and underpins sustained growth across the smart healthcare products market.

Smart Healthcare Products Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

The competitive arena is moderately concentrated, with the top three manufacturers—Philips Healthcare, Abbott, and Medtronic—controlling significant revenue, while a long tail of niche providers supplies specialised hardware and software modules. Industry rivalry centres on platform interoperability rather than outright hardware displacement, prompting alliances between medtech incumbents and cloud hyperscalers.

Strategic partnerships typify current strategy. Abbott linked its continuous glucose monitoring sensor to Medtronic insulin pumps, unlocking an estimated USD 700-850 million incremental market[3]Abbott, “Global Partnership to Connect CGM Sensors with Insulin Delivery Devices,” abbott.mediaroom.com. GE HealthCare collaborates with Amazon Web Services to co-develop generative-AI diagnostic tools, leveraging AWS’s machine-learning stack to analyse multi-modal data. Medtronic’s tie-up with Philips integrates pulse oximetry and capnography into Philips’ monitoring systems, expanding access for hospitals seeking a unified user interface.

Acquisition activity targets digital platforms and AI algorithms. Boston Scientific’s focus on interventional cardiology and Johnson & Johnson’s investment in robotic surgery illustrate buyers’ intent to control data-rich ecosystems. Venture capital funds channel resources into start-ups offering device-agnostic analytics, potentially positioning them as acquisition targets. Price competition remains contained due to regulation and high switching costs, while intellectual-property portfolios provide defensive moats. Continuous product improvements and recurring software upgrades sustain margin profiles and support future cash flow across the smart healthcare products market.

Smart Healthcare Products Industry Leaders

  1. Abbott Laboratories

  2. GE Healthcare

  3. Koninklijke Philips N.V.

  4. Medtronic plc

  5. Siemens Healthineers AG

  6. *Disclaimer: Major Players sorted in no particular order
Smart Healthcare Products Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • July 2025: Medtronic announced a strategic partnership with Philips to integrate next-generation Nellcor pulse oximetry and Microstream capnography into Philips’ patient-monitoring systems, broadening global access to advanced respiratory insights.
  • June 2025: The FDA approved the Sonu Band, an AI-enabled wearable that treats moderate-to-severe nasal congestion in adolescents, providing the first drug-free solution for rhinitis that demonstrates over 80% user improvement within 15 minutes.

Table of Contents for Smart Healthcare Products Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption Of Iot-Enabled Medical Devices
    • 4.2.2 Escalating Chronic-Disease Burden & Ageing Demographics
    • 4.2.3 Government Incentives For Digital-Health Infrastructure
    • 4.2.4 Broader Reimbursement For Telemedicine Services
    • 4.2.5 Wearable Ultrasound & Smart Textiles For Continuous Care
    • 4.2.6 Energy-Efficient Lightweight Cryptography Unlocking Ultra-Low-Power Sensors
  • 4.3 Market Restraints
    • 4.3.1 High Capital Cost Of Smart Healthcare Ecosystems
    • 4.3.2 Cyber-Security & Data-Privacy Concerns
    • 4.3.3 BLE Protocol Vulnerabilities Triggering Compliance Delays
    • 4.3.4 Supply-Chain Fragility For Advanced Mini-Sensors
  • 4.4 Technological Outlook
  • 4.5 Porter's Five Forces
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers / Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Telemedicine
    • 5.1.2 Electronic Health Records
    • 5.1.3 mHealth Solutions
    • 5.1.4 Smart Pills
    • 5.1.5 Smart Syringes
    • 5.1.6 Smart RFID Cabinets
    • 5.1.7 Smart Wearable Devices
    • 5.1.8 Smart Hospital Infrastructure
  • 5.2 By Application
    • 5.2.1 Storage & Inventory Management
    • 5.2.2 Remote Monitoring
    • 5.2.3 Diagnostics
    • 5.2.4 Treatment & Drug-Delivery
    • 5.2.5 Wellness & Preventive Care
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Home-Care Settings
    • 5.3.3 Specialty Clinics
    • 5.3.4 Ambulatory Surgical Centers
    • 5.3.5 Long-Term Care Facilities
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.4.3.1 Saudi Arabia
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Abbott Laboratories
    • 6.3.2 Medtronic plc
    • 6.3.3 GE Healthcare
    • 6.3.4 Siemens Healthineers AG
    • 6.3.5 Koninklijke Philips N.V.
    • 6.3.6 Samsung Medison Co. Ltd.
    • 6.3.7 McKesson Corporation
    • 6.3.8 Oracle Corporation (Cerner)
    • 6.3.9 NextGen Healthcare Inc.
    • 6.3.10 Olympus Corporation
    • 6.3.11 Capsule Technologies Inc.
    • 6.3.12 Omron Healthcare Co. Ltd.
    • 6.3.13 Teladoc Health Inc.
    • 6.3.14 DexCom Inc.
    • 6.3.15 Apple Inc.
    • 6.3.16 Allscripts Healthcare Solutions Inc.
    • 6.3.17 IBM Corporation (Watson Health)
    • 6.3.18 Cisco Systems Inc.
    • 6.3.19 Boston Scientific Corporation
    • 6.3.20 iRhythm Technologies Inc.

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Smart Healthcare Products Market Report Scope

As per the scope of the report, smart healthcare products improve outcomes related to diagnostic tools and enhance patient treatment, along with improving their quality of life. Smart health products come with embedded communication, sensor technologies, and data analytics techniques. These products are used for monitoring individuals physically for diagnosis and ongoing disease treatments. 

The smart healthcare products market is expected to register a CAGR of 8.5% over the forecast period. The smart healthcare products market is segmented by product type (telemedicine, electronic health records, mHealth, smart pills and syringes, and smart RFID cabinets), application (storage and inventory management, monitoring, treatment, and other applications), end user (hospitals, home care settings, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the market size and forecasts in value (USD million) for the above segments.

By Product Type
Telemedicine
Electronic Health Records
mHealth Solutions
Smart Pills
Smart Syringes
Smart RFID Cabinets
Smart Wearable Devices
Smart Hospital Infrastructure
By Application
Storage & Inventory Management
Remote Monitoring
Diagnostics
Treatment & Drug-Delivery
Wellness & Preventive Care
By End User
Hospitals
Home-Care Settings
Specialty Clinics
Ambulatory Surgical Centers
Long-Term Care Facilities
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa Saudi Arabia
South America Brazil
Argentina
Rest of South America
By Product Type Telemedicine
Electronic Health Records
mHealth Solutions
Smart Pills
Smart Syringes
Smart RFID Cabinets
Smart Wearable Devices
Smart Hospital Infrastructure
By Application Storage & Inventory Management
Remote Monitoring
Diagnostics
Treatment & Drug-Delivery
Wellness & Preventive Care
By End User Hospitals
Home-Care Settings
Specialty Clinics
Ambulatory Surgical Centers
Long-Term Care Facilities
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa Saudi Arabia
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the smart healthcare products market?

The market stands at USD 223.98 billion in 2025 and is projected to reach USD 386.00 billion by 2030 with an 11.5% CAGR.

Which product category holds the largest share?

Electronic Health Records lead with 28.51% revenue share in 2024 due to mandated digitisation programmes.

Why is Asia-Pacific witnessing the fastest growth?

Coordinated government funding, expanding healthcare infrastructure, and rising chronic-disease prevalence drive a 17.31% CAGR in the region.

How do cybersecurity regulations impact adoption?

Stricter HIPAA and GDPR rules raise compliance costs and lengthen development timelines, moderating near-term device rollouts.

What role do strategic partnerships play in market competition?

Alliances allow companies to integrate complementary technologies, accelerate product roadmaps, and enhance interoperability without major acquisitions.

Page last updated on:

Smart Healthcare Products Report Snapshots